ArticleScientific reports2022

Evaluation of S100A12 and Apo-A1 plasma level potency in untreated new relapsing-remitting multiple sclerosis patients and their family members.

Mahsa Samangooei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.